Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Sjögren disease carries a serious mortality risk that goes beyond its hallmark symptoms. A large Australian study found that patients with primary Sjögren disease (SjD) face an 80% higher risk of death compared to matched controls, with infections, heart disease, and interstitial lung disease as the leading causes. The risk climbs even higher when SjD occurs alongside rheumatoid arthritis or other connective tissue diseases.
Sjögren disease carries a serious mortality risk that goes well beyond its hallmark symptoms of dry eyes and dry mouth. A large data linkage study out of Western Australia found that patients with primary Sjögren disease (SjD) face an 80% higher risk of death compared to matched individuals without the disease. Over 25 years, patients with SjD showed 23% lower relative survival than the general population, with infections, cardiovascular disease, and interstitial lung disease emerging as the leading causes of death.
The risk is compounded when SjD occurs alongside other conditions. Patients with SjD plus rheumatoid arthritis had a 2.1-fold higher risk of death, while those with SjD plus another connective tissue disease faced a 3.1-fold higher risk compared to controls. Interstitial lung disease showed the strongest individual association with death, and pulmonary circulation disorders carried a particularly elevated risk.
By the Numbers:
Why it matters: Clinicians often focus on symptom management in SjD, but this study highlights the importance of prioritizing cardiovascular risk factor management and infection prevention early in the disease course — steps that could meaningfully improve long-term survival.